Table 1.
Sociodemographic and disease specific characteristics (exact p-values are reported for two-way chi-square tests between the intervention and usual care arms).
| Entire Sample (N = 261) |
Clinically Significant Symptoms (N = 132) |
|||
|---|---|---|---|---|
| Variable | n (%) | Intervention vs Usual Care p-value |
n (%) | Intervention vs Usual Care p-value |
| Gender (n, % male) | 190 (73) | 0.577 | 94 (71) | 0.128 |
| Age (Mean, SD) | 61 (11) | 0.751 | 60 (11) | 0.707 |
| Race (n, %) | 0.779 | 0.188 | ||
| Caucasian | 224 (86) | 111 (84) | ||
| African American | 24 (9) | 16 (12) | ||
| Asian-American | 3 (1) | 1 (1) | ||
| Hispanic | 1 (0) | |||
| Other | 1 (0) | |||
| Diagnosis | 0.897 | 0.211 | ||
| HCC and CCC | 167 (64) | 80 (61) | ||
| Other Primary Cancers with Liver Metastases | 94 (36) | 52 (39) | ||
| Treatment (n, %) | 0.145 | 0.505 | ||
| Regional Therapy | 133 (51) | 68 (52) | ||
| Surgery | 54 (21) | 29 (22) | ||
HCC=Hepatocellular carcinoma; CCC=Cholangiocarcinoma